MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 232 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $743,825 | +204.4% | 2,655 | +190.2% | 0.01% | +116.7% |
| Q1 2024 | $244,342 | -54.3% | 915 | -60.4% | 0.01% | -14.3% |
| Q4 2023 | $534,950 | +77.8% | 2,312 | +12.2% | 0.01% | -22.2% |
| Q3 2023 | $300,842 | -23.1% | 2,060 | +21.7% | 0.01% | -30.8% |
| Q2 2023 | $391,083 | +372360.0% | 1,693 | +291.0% | 0.01% | +333.3% |
| Q1 2023 | $105 | -88.8% | 433 | -86.6% | 0.00% | -92.3% |
| Q4 2022 | $941 | -99.8% | 3,242 | -44.1% | 0.04% | +550.0% |
| Q3 2022 | $377,000 | +113.0% | 5,795 | +133.4% | 0.01% | +50.0% |
| Q2 2022 | $177,000 | +73.5% | 2,483 | +138.5% | 0.00% | +300.0% |
| Q1 2022 | $102,000 | -41.0% | 1,041 | -49.0% | 0.00% | -66.7% |
| Q4 2021 | $173,000 | +71.3% | 2,043 | +61.6% | 0.00% | 0.0% |
| Q3 2021 | $101,000 | -54.9% | 1,264 | -45.1% | 0.00% | -50.0% |
| Q2 2021 | $224,000 | +339.2% | 2,303 | +425.8% | 0.01% | +500.0% |
| Q1 2021 | $51,000 | +1175.0% | 438 | +1023.1% | 0.00% | – |
| Q4 2020 | $4,000 | -92.2% | 39 | -91.0% | 0.00% | -100.0% |
| Q3 2020 | $51,000 | -75.6% | 434 | -76.5% | 0.00% | -88.9% |
| Q2 2020 | $209,000 | +226.6% | 1,848 | +92.9% | 0.01% | +125.0% |
| Q1 2020 | $64,000 | +326.7% | 958 | +477.1% | 0.00% | +300.0% |
| Q4 2019 | $15,000 | -63.4% | 166 | -65.4% | 0.00% | -66.7% |
| Q3 2019 | $41,000 | -6.8% | 480 | +201.9% | 0.00% | +50.0% |
| Q2 2018 | $44,000 | +2100.0% | 159 | +783.3% | 0.00% | – |
| Q1 2018 | $2,000 | -80.0% | 18 | -92.0% | 0.00% | -100.0% |
| Q3 2017 | $10,000 | +150.0% | 225 | -14.8% | 0.00% | – |
| Q2 2017 | $4,000 | -55.6% | 264 | -56.0% | 0.00% | -100.0% |
| Q1 2017 | $9,000 | +125.0% | 600 | +100.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 300 | -12.0% | 0.00% | – |
| Q3 2016 | $4,000 | – | 341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |